24-wk Efficacy and Safety of Flibanserin vs Pbo in Naturally Postmenopausal Women in United States
24-wk Efficacy and Safety of Flibanserin vs Pbo in Naturally Postmenopausal Women in United States
The objective of this trial is to assess the safety and efficacy of 24-week course of flibanserin for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in naturally postmenopausal women.
Inclusion criteria:
Exclusion criteria:
Washington D.C., District of Columbia, United States